One of the companies operating within IGU TEKMER, Cistron Biologics Molecular Research Development Industry and Trade Inc. was entitled to receive support within the scope of TUBITAK's 1507 SME R&D Start-up Support Program 2024-2 call.
The company within TEKMER aims to take a significant step in the field of biotechnology with its project titled "Development of Recombinant Manufacturing Process of Reverse Transcriptase Enzyme and One-Step Reverse-Transcriptase PCR Kit". The project focuses on the development of molecular biology and diagnostic kits that play a critical role during epidemic periods.
The one-step RT-PCR kit to be developed aims to provide fast and effective results by combining both RT (Reverse Transcriptase) and PCR reactions in one step. This innovative product will fill a significant gap in biotechnological solutions, especially by accelerating diagnostic processes.
While the project budget is determined as 2.398.097 TL, this study is expected to contribute to the competitiveness of our country in the field of biotechnology.
With this successful project, TEKMER once again demonstrates Türkiye's R&D and innovation capacity.
Created Date: : Friday, January 17, 2025
For students preparing for the YKS, the February break is seen as an import...
The FIDE Women’s World Team Chess Championship, held in November 2025 in Li...
0212 422 70 00
